They cited 4 myths about bipolar depression treatment that have either been disproved or are not supported by current evidence: (1) bipolar disorder is not a lifelong illness and episodes only ...
Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.
Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company currently valued at $5.8 million and showing promising revenue growth of 62% over the last twelve months, announced the release of two ...
Key Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...
Artificial Intelligence has proven to positively transform a wide range of sectors. Healthcare is one such sector that has ...
ITV News understands targets for mental health care have been removed from formal instructions due to be issued to NHS bosses ...
President Donald Trump has signed multiple executive orders in January aimed at making changes in the military. Here's how it ...
Discover why Johnson & Johnson is a top stock pick for income investors in 2025 with strong sales growth and promising ...
An emerging field of genetics promises to let parents choose the “healthiest” baby.
CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, ...
Potential antitrust deregulation could foster a more favourable environment for larger M&A deals, though skepticism remains.
Ultimately Shraddha was diagnosed with the milder Bipolar 1 Disorder. The treatment plan consisted of medications and psychotherapy. Shraddha was given medications to stabilise her moods. She also ...